In its thirteenth acquisition in only four years, CarePoint Partners, a portfolio company of Waud Capital Partners, will acquire the infusion business of ArTex Medical Inc. Terms of the deal were not released. CarePoint is an independent infusion therapy provider. Waud Capital is a middle-market private equity investment firm.
Waud Capital Partners (“WCP”) announced that its portfolio company, CarePoint Partners (“CarePoint” or the “Company”), has acquired the infusion business of ArTex Medical, Inc. (“ArTex”), marking its 13th acquisition in under four years. CarePoint is one of the largest and most acquisitive independent infusion therapy providers in the United States, serving over 3,000 patients per day at 25 sites of service across nine states. Terms of the transaction are not being disclosed.
ArTex operates three sites of service in Texas (Dallas and Texarkana) and Louisiana (Shreveport). With the acquisition of ArTex, the largest completed by CarePoint to date, the Company adds to its strategic presence in the Dallas metropolitan area, the fourth-largest addressable market in the United States. ArTex provides a range of cardiology, nutrition, infectious disease and neurology clinical support programs. It will continue to operate under the “ArTex” name, maintaining the same team of infusion professionals that has been integral to its success to date.
“The ArTex acquisition brings several benefits to CarePoint Partners,” said Dana Soper, CarePoint’s Chief Executive Officer. “The three sites of service further expand our reach within Texas and Louisiana. ArTex’s therapy mix strengthens our position as a leading independent home infusion provider nationally. Most importantly, ArTex has built and developed a high-caliber team of employees that we are excited to bring into the CarePoint family.”
In conjunction with the acquisition, CarePoint completed a $68 million senior debt refinancing, led by Madison Capital and MidCap Financial. The credit facilities significantly increase the amount of committed capital available to support CarePoint’s growth and acquisition initiatives. Madison Capital acted as the administrative agent on the facilities, with both lenders serving as joint lead arrangers.
Matt Clary, Partner at WCP, commented, “We are pleased to complete the ArTex acquisition, which is quite meaningful for the Company. CarePoint has been able to establish five sites of service within Texas in the past eight months. We remain excited about CarePoint’s prospects for growth, both through acquisition and organically, in Texas and other large, targeted markets.”
Commenting on the financing, Eric Gordon, Vice President at WCP, offered, “We are thrilled to expand our relationship with Madison Capital and are pleased to welcome MidCap as a joint lead arranger. Both institutions have shown a commitment to support CarePoint’s growth strategy.”
About CarePoint Partners
WCP teamed with Chief Executive Officer Dana Soper in 2007 to form CarePoint Partners to acquire, develop and operate a network of home infusion and specialty pharmacies. Based in Cincinnati, CarePoint provides home infusion therapy and specialty pharmacy services via 25 sites of service in nine states. Infusion pharmacy therapy involves the administration of medications and nutrients using intravenous, subcutaneous and epidural methods. Home infusion therapy allows patients to receive these medications without the inconvenience or cost of a hospital visit.
About Waud Capital Partners
WCP is a leading middle-market private equity investment firm founded in 1993 that partners with exceptional management teams to invest in growth equity investments, industry consolidations, buyouts and recapitalizations. The firm seeks to invest $10 million to $100 million in private companies in the following four areas: healthcare services, business and consumer services, specialty distribution and value-added industrial businesses. Typically, the companies in which WCP invests have enterprise values between $30 million and $300 million.